RPS6KA3 and melanoma: As opposed to the melanoma cells, primary human fibroblasts and keratinocytes, which were used as benign control cells of the skin, were only marginally affected by treatment with RSK inhibitors (Supplementary Figure 3C), suggesting the observed effect of RSK inhibition to be specific to melanoma cells.